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Abstract
Multidimensional fluorescent chemosensor data looking at the effect that rhodamine
boronic acid dyes and fluorescein aldehyde dyes have on analytes of interest was
collected by the Strongin Research Group. These sets of data have resulted in great
qualitative results. A method to quantify the results, however, was desired. The major
objective of this research was to reanalyze these sets of data using a new
multidimensional analysis technique called Parallel Factor Analysis (PARAFAC) to
obtain quantitative results. PARAFAC was performed on the data and new promising
quantitative results were obtained. The promising results offered assertion of the use of
PARAFAC on future studies of new multidimensional fluorescent chemosensor data.
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1) Fluorescent Dyes and Analytes of Interest

1

The Strongin Research Group has done many studies on the effect of dyes on the
fluorescent spectrum of a sample. Each study that was done on the dyes resulted in new
information regarding ways to change the selectivity of the results by tweaking the
conditions of the initial samples. It was found that multiple dyes have the ability to detect
different classes of analytes. The dyes are all different colors, covering different regions
of the spectra. A typical multidimensional fluorescence spectrum is an excitation
emission matrix (EEM). An EEM can be thought of as a collection of a series of emission
spectra over a wide range of excitation wavelengths. All of the excitation and emission
spectra can be extracted from an EEM. If we slice at a particular excitation wavelength,
such as 280nm, the slice we get will be an emission spectra excited at 280 nm.
Conversely, if sliced the opposite way, at an emission wavelength at 280nm, it would
result in an excitation spectra at this emission wavelength. Compared to only collecting a
single pair of excitation and emission spectra, an EEM can provide more information
because it covers all the wavelengths. EEMs make it easy to observe wavelength shifts
and are ideal for a mixture of several components1. The fact that the dyes studied by the
group are all different colors, they are able to cover all regions of the EEMs. Two dyes of
interest in the Strongin Research Group are aldehyde-bearing fluorophores and
rhodamine boronic acid (RhoBo).
One type of dye that has been extensively studied by the research group is
aldehyde-bearing fluorophores. Aldehyde-functionalized probes, such as fluorescein
aldehyde, studied by Strongin et. al., are green and are used for the “optical detection of
amino thiols,2” such as cysteine and homocysteine. Three different fluorescein aldehydes
have been studied to determine selectivity for thiols: fluorescein mono aldehyde,
2

dialdehyde, and an unsaturated aldehyde. Both mono aldehyde and dialdehyde and their
reaction to cysteine and homocysteine were studied in a sodium bicarbonate buffer, at a
pH of 9.5. The reaction between mono aldehyde and dialdehyde with cysteine and
homocysteine resulted in a yellow-to-orange color change and a shift in the absorbance
maxima. Both mono and dialdehyde responded to the analytes, but dialdehyde had better
selectivity. It was also found that there was a quenching-based response towards both
analytes. The reason for this quenching response is photo induced electron transfer (PET)
of the lone pair of electrons on the nitrogen1.
In their paper, “Differences in heterocycle basicity distinguish homocysteine from
cysteine using aldehyde-bearing fluorophores,” Strongin et al continued to look into
fluorescein aldehydes reacting with cysteine and homocysteine. This study investigated
the reaction between the probe and analytes at low pH, rather than a high pH like
previous studies had investigated. Low pH solutions resulted in PET inhibition, as
hypothesized, resulting in fluorescent enhancement. Fluorescence of the probe was
enhanced by homocysteine when the pH was changed from 5.5 to 6.0, but cysteine did
very little to enhance the fluorescence. This difference in basicity between cysteine and
the fluorescein aldehyde probe (pKa=.57) and homocysteine and the fluorescein aldehyde
probe (pKa=6.7) allows for the selectivity of homocysteine over cysteine in basic
solutions.
Like the color change observed when cysteine and homocysteine reacted with
mono and dialdehyde, the absorbance spectra of fluorescein aldehydes with other thiols
also change color, as shown in Figure 1. Figure 1 shows the different colors of a
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fluorescein aldehyde probe with common tthiols such as L-methionine,
methionine, mercaptoethanol,
and glutathione
tathione along with amino acids3,4.

Another dye that has been extensively studied is Rhodamine boronic acid (RhoBo).
RhoBo is a unique boronic acid dye that detects sugars and is used as a chemosensor.
Most boronic acids preferentially respond to fructose and fructose derivatives. RhoBo,
however, is unique because un
under
der certain conditions it is selective to ribose and ribose
derivatives5. The change of selectivity of RhoBo is due to binding interactions between
the dye and the sugars. RhoBo is
a wavelength and time dependent
dye. There are three rhodamine
boronic dyes of interest,, shown in
Figure 2, one that is red, and two
that absorb and emit at longwavelengths—one that emits and
absorbs at a longer red
nearwavelength and one that is near
IR4.
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One important study that the Strongin Research Group has used RhoBo in was that
regarding the detection of adenylosuccinase deficiency (ADSL deficie
deficiency).
ncy). ADSL is a
rare inborn error of purine metabolism that is contained within the broad autism spectrum.
It is a very difficult disease to detect and is often underreported and misdiagnosed. It is
for this reason that new ways of detecting
ADSL are important.
Ado and SAICar, shown
The substrates S-Ado
in Figure 3, are a key to diagnosing ADSL.
Table 1 shows the concentrations of these two
substrates and AICAr in urine in both healthy
patients and those with ADSL deficiency. As
you can see in the table, levels of both
substrates are not present in healthy patients but
are very high in concentration in ADSL deficient patients. While S-Ado
Ado and SAICAr
SAIC are
the substrates key to diagnosing ADSL deficient patients, neither of them are
commercially available.. AICAr, also shown in Figure 3, is structurally similar to both SS
Ado and SIACAr and is commercially available. It is for this reason that it is used as a
model compound in studies related to ADSL6. RhoBo was key to studying human
hum urine
for ADSL deficiency because of its ability to react to ribose and ribose derivatives.
AICAr is a ribose derivative.

5

In their experiment, highlighted in “Progress Towards Simple and Direct Detection
of Adenylosuccinase Lyase Deficiency in Human Urine,” RhoBo was used in a 5 percent
human urine mixture. AICAr was added via standard addition and the excitation emission
spectra was recorded after each addition, shown in Figure 4 (a, b and c). This study
showed that it was possibly to detect AICAr in human urine and that the concentration
increased linearly when spiked shown in Figure 4d. This result was promising due to
urine being a complex matrix containing lots of other sugars and potential interferences.
However, there were still setbacks in the resulting data. Figure 4a is the EEM of RhoBo
in a 5% urine mixture. There is a fair amount of signal, and the peak looks similar to that
of fructose. Figure 4bb shows the EEM upon tthe
he addition of AICAr; as is apparent,
apparent there is
a long wavelength peak that was not present in 4a,
a, but still a large amount of background
interferences making it hard to see the ppeak.
eak. To more clearly see this peak, the EEMs can
be subtracted, giving 4c, in order to
see the long wavelength peak.
Although the intensity was shown
to be linear as AICAr was added,
subtracting the control can
potentially
ally hamper quantification. It
was for this reason that a better way
to remove interferences
rferences to quantify
the data was desired7.
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A second study done on RhoBo, highlighted
in “Detecting specific saccharides via a single
indicator,” looked at RhoBo in response to
different analytes. RhoBo was first combined
with AICAr and Fructose
ose individually and EEMs
of these two mixtures, along with a control EEM
of just RhoBo, were recorded to demonstrate its
response to different analytes, shown in Figure 5.
As is evident from the EEMs, different analytes in
different spectral regions allow a single indicator,
such as RhoBo, to detect multiple analytes8.
To show RhoBo’s dependence on time and
wavelength using a single indicator, an EEM of
RhoBo with AICAr, fructose
ructose and mixtures of the
two were scanned every
very 4 minutes for an hour.
Taking EEMs over time allowed us to work with
complex mixtures. The resulting EEMs, shown in
Figure 6, show qualitatively that there are
differences between each analyte. EEMs of the
mixtures had characteristics of each analyte,
analyte but
the mixture that contained mostly AICAr resulted
in an EEM looking more like the AICAr EEM
and the mixture that contained mostly fructose
7

resulted in an EEM looking more like the fructose EEM. Though these visual differences
were apparent, methods of quantitatively analyzing this data were desired. This study
showed that a single indicator could be used to selectively qualitatively distinguish
structurally related sugars simultaneously7. A powerful method to analyze
multidimensional data is a method called Parallel Factor analysis (PARAFAC). Using
this tool, the data from these studies could be analyzed and quantified.
Along with the desire for quantitative methods of analysis for these past studies, the
idea of using a combination of both RhoBo and fluorescein aldehydes in future studies is
of interest to the group. Combined with the autofluorescence of an analyte, both RhoBo
and fluorescein aldehydes make it possible to measure the entire spectrum of EEMs.
RhoBo covers from red to near-IR region of the spectra, fluorescein aldehydes cover the
green range of the spectra and autofluorescence detects short wavelengths. Together,
more of the spectra of each EEM could be covered, enabling better interpretation of data.

8

2) Multi-way Analysis
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Multidimensional fluorescence as a metabonomic tool has many advantages. The
method is very simple and has a rapid acquisition time. The method can analyze large
sets of data and is very sensitive. Multidimensional data has been used before to detect
diseases. Wavelength pairs and ratios, along with pattern recognition were used for this
type of analysis in the past. Now chemometrics and PARAFAC are applied because they
are believed to be a better method9.
Parallel Factor Analysis (PARAFAC) is a very powerful multi-way decomposition
method used in chemometrics. When there are multiple components in a sample, peaks of
different components can overlap with each other, leading to more complex spectra. In
order to know what each of the components are, the components need to be extracted into
individual parts. PARAFAC can be used to extract the spectra of different components
from the matrix. In, “PARAFAC. Tutorial and applications,” a paper by Bro, et al, the
uses of PARAFAC are discussed. Bro, et al, created a Matlab toolbox, called the N-Way
toolbox, which is an extension needed to complete PARAFAC. This paper discusses the
different analysis that the toolbox can do to analyze the data collected in the fluorometer3.
To use PARAFAC, Excitation Emission Spectrums (EEMs) are first collected. These
EEMs are then combined to make a three dimensional matrix. PARAFAC is then run,
decomposing this data into its distinct components. PARAFAC shows different analytes
in mixtures and can give information on their concentrations and spectra1.
In hopes to find a method to quantitatively analyze data collected, the data from the
previous studies mentioned above was reanalyzed using PARAFAC.
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3) Reanalysis Using Multi-Way Analysis
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The data collected in the afore mentioned studies involving RhoBo and
fluorescein aldehyde dyes accounted for multiple dimensions, but were not looked at as
such. The results of these studies gave good qualitative analysis of the data, but methods
to quantify the data were desired. With PARAFAC, these multiple dimensions could be
taken into account and quantitative analysis could be done.
The data shown above in Figure 6 is one set of data that was analyzed with PARAFAC.
When PARAFAC was performed, each EEM was decomposed into a weighted sum of
two species, a short and long wavelength. Each of these two species had an emission and
excitation peak, shown in Figure 7. Figure 7a shows the short wavelength component and
Figure 7b shows the long wavelength component. It was observed in previous studies that

the optimum wavelength for quantification of AICAr was at a long wavelength spectrum,
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similar to the long wavelength component shown in Figure 7(a). Similarly, the optimum
wavelength for quantification of interference spectra in past studies was found to be at a
short wavelength spectrum, similar to the short wavelength component shown in Figure
7(b).
PARAFAC was used to extract the data into its separate components and these
components change over time. The magnitude of each component and how they changed
over time was then graphed for AICAr and fructose, shown in Figure 8. These plots show
the score, which corresponds to the concentration of each component, as they change
over time. The manner in which each component changes over time, along with the
magnitudes for each, varies from analyte to analyte. AICAr (Figure 8(a)) has a long
wavelength component that steadily increases, plateaus at about 30 minutes and then
decreases. The short wavelength component stays relatively constant. Fructose (Figure
8(b)) has a long wavelength component that starts high and decreases over time, while
the short wavelength component starts low and increases. Qualitatively, these two data
sets appear very different. One way to show these differences in a quantitative method
was to plot the ratio of the two as they change over time, so this was done for each; the
plot of the ratio is shown in black in both graphs in Figure 8. The ratio of AICAr was
clearly different than the ratio for fructose.
To further see how the ratio changes as the AICAr and fructose mixture changes, the
mixtures were investigated at one point in time. Figure 9 shows the EEMs that were
looked at to determine this ratio, which corresponds to the fourth row of EEMs in Figure
6, recorded after about 15 minutes. Qualitatively, it was evident that the EEM for AICAR
is different than that of fructose. Features of both can be seen in the three mixtures,
13

though those that are AICAr heavy have
features dominated
inated by long wavelength
peak, like AICAr and those mixtures that
are heavy in fructose are dominated by
short wavelength,, similar to fructose.
fructose The
ratio plotted as a function of AICAr
concentration in the mixture was then
plotted, Figure 10. Plotted as a function
of AICAr concentration, the ratio
generally increased with increasing AICAr.
This result was promising
mising and indicative
of the ability to quantitatively analyze similar data in the future.
The second study with RhoBo in “Progress Towards Simple and Direct Detection of
Adenylosuccinase Lyase Deficiency in Human Urine,” dealt with a more complex matrix,
human urine. Complex matrices such as this often have large interferences. A way to
remove interferences in complex matrices was desired. PARAFAC provided a route to do
that. As shown again in Figure 11(a
11(a-c),, the EEMs in presence of urine have large
larg short
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wavelength interference. PARAFAC completely resolved the background peak and
isolated it the two components of the sample, leaving the peak of interest to be analyzed.
The short wavelength species did not change upon spiking with AICAr, but the long
wavelength species increased linearly as expected (Figure 12). When PARAFAC was run,
the interference was eliminated, saving time and leaving less room for the data to be
hampered with. Though PARAFAC resolved the background peak there was still an
indicator background present, which needs to be minimized before any standard addition
procedures are done.

15

4) Future Work
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One short-term goal for future research is to analyze global data sets instead of at
just one time point for data collected over a longer period of time. It is hypothesized that
analysis of global data sets would further improve quantitative analysis.
Lawaetz, et al, first introduced the idea of using multi-way analysis for
metabonomic diagnostics. Metabonomic diagnostics is based on non-targeted
measurements of metabolites in biological systems usually using nuclear magnetic
spectroscopy (NMR), liquid chromatography (LC) and gas chromatography (GC)
combined with mass spectroscopy (MS).10,11 In their paper, "Fluorescence Spectroscopy
as a Potential Metabonomic Tool for Early Detection of Colorectal Cancer," they used a
PARAFAC, to try to detect Colorectal Cancer.
The main purpose of the paper was to discuss the use of fluorescent spectroscopy
as a tool for the detection of colorectal cancer and how this technique could be used as a
metabonomic tool. The study used two different control groups, healthy patients (or
patients with non-malignant findings) and patients with colorectal cancer. Excitation
Emission Spectrum (EEM) were collected on their plasma and were then analyzed using
PARAFAC to look for differences in the chemical components. This method showed
shifts in the Tryptophan emission of cancer patients, which confirmed previous findings
by other methods; the method also showed much clearer results.12 The paper proved that
this method of analysis could be used to detect chemical changes correlated with a
disease, which is why we hypothesize that this same method could be used for the
detection and diagnoses of sepsis.
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Sepsis is a serious bloodstream infection that can rapidly become life-threatening.
A clinical syndrome, sepsis is defined by the presence of both system inflammatory
response and infection in the body that can arise from various infections, such as those
“from the skin, lungs abdomen, and urinary tract13,14.” In the United States alone, over
1.1 million people are affected yearly by sepsis. On average, 36 people die per hour
because of the disease8. Despite medical advancements, sepsis is slowly becoming more
common in patients15 and though they are treated with high expenditures, sepsis is more
often than not, fatal. Though not all have fatal encounters with sepsis, people who survive
are likely to live with organ damage, cognitive impairment and physical disabilities8.
Historically, sepsis has been diagnosed via a broad set of symptoms including
abnormalities in body temperature, heart rate, respiratory rate, and white blood cell count.
When two or more symptoms of systematic inflammatory response syndrome (SIRS) are
present, infection is considered to be sepsis. Symptoms of the systematic inflammatory
response syndrome include: ‘body temperature higher than 38°C or lower than 36°C;
heart rate higher than 90/min or more than two SD above the normal value for age;
tachypnea; alterations in the white blood count, and the presence of more than 10 percent
immature neutrophils’. More severe forms of sepsis include sepsis in association with
organ dysfunction, hypoperfusion and hypotension. Septic shock is sepsis with arterial
hypotention7.
Sepsis detection is often delayed because of the non-specific symptoms and the
time-consuming lab techniques. The time that it takes for diagnostics is very important
however because there is a 7.6% increase in mortality for every hour that a patient
remains undiagnosed or untreated16. Currently, the main clinical method for diagnosis of
18

sepsis is blood testing. This method of diagnosis is very time consuming. Early detection
of sepsis is key in lowering the rate of mortality17, making blood testing very inefficient.
Blood testing is difficult and less effective for neonates because they do not have the
amount of blood needed and they are often asymptomatic until respiratory collapse is a
danger. The amount of blood required for testing is two samples of 20-30 ml11. Because
of this, neonates are often treated with antibiotics that can cause major side effects, such
as deafness and renal failure in newborns that are misdiagnosed with sepsis18.
As stated above, blood testing is very time-consuming. The incubation period
takes at least 8 hours and can take upwards of 96 hours19. Culture reports are then ready
in 24-48 hours11. Cultures come out negative almost 50% of the time when severe sepsis
is sampled after antibiotics administration20. It is for this reason that new methods of
detection are beginning to be investigated.
Now that new methods of analysis, such as PARAFAC, have been explored, the
future goal of the research project is to apply this fluorescent-based metabonomic
approach to early diagnoses of sepsis. There are several biomarkers in blood that
autofluoresce, which would allow healthy patients to be distinguished from those with
disease. If the autofluorescence is combined with a rhodamine boronic acid dye, a
fluorescein aldehyde dye, or a combination thereof and PARAFAC, it is predicted that
the potential to detect shifts in the chemical composition of known biomarkers would
increase.
The process of this future research has many aspects to it, making this a long-term
goal for the group. In order to determine any trends, hundreds of samples will be needed
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for analysis. Due to the samples being plasma samples from sick and healthy patients, the
institutional review board will have to approve of the research and many clinical studies
will need to be completed.
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5) Concluding Remarks
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Much research has been done on the effect that rhodamine boronic acid (RhoBo)
and fluorescein aldehyde have on fluorescent spectra of analytes. Both dyes can be tuned
in order to detect analytes of interest. RhoBo is wavelength and time dependent and is
selective towards ribose and ribose derivatives. Fluorescein aldehyde is selective towards
thiols.
Parallel Factor analysis (PARAFAC) provides a multi-dimensional way to
analyze EEM’s and decompose them into their components. Decomposing EEMs
provides a better way to quantitatively analyze large sets of data, thus improving results.
Work is ongoing to improve the results of PARAFAC analysis, including tailoring future
experiments to assure proper data collection. Analysis of more global data sets is also
ongoing, as it is hypothesized that these larger sets of data will further improve
quantitative analysis of data collected.
A long-term goal of the research group is to use RhoBo and fluorescein aldehyde,
along with PARAFAC to detect and diagnose sepsis. Doing so would provide a faster,
more efficient way of diagnosing.
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